Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime
Open Access
- 1 August 1993
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (8) , 1696-1700
- https://doi.org/10.1128/aac.37.8.1696
Abstract
In a multicenter study, the MICs of FK-037 for 90% of the strains tested (MIC90s) were < or = 1 microgram/ml for members of the family Enterobacteriaceae other than Citrobacter freundii, Enterobacter spp., and Serratia marcescens. Activity against Pseudomonas aeruginosa was variable, with a MIC50 and a MIC90 of 4 and 32 micrograms/ml, respectively. Relative to cefepime, however, FK-037 was less active against ceftazidime-resistant isolates of Enterobacter cloacae. The MIC90 of FK-037 for methicillin-resistant staphylococci was > 16 micrograms/ml.Keywords
This publication has 6 references indexed in Scilit:
- In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporinAntimicrobial Agents and Chemotherapy, 1993
- In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1993
- Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for Class I β-lactamseJournal of Antimicrobial Chemotherapy, 1989
- Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsAntimicrobial Agents and Chemotherapy, 1989
- Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime.1989